Profil
Charles A. Nicolette formerly worked at CoImmune, Inc., as Chief Executive Officer & Director, Genzyme Molecular Oncology, as Director-Antigen Discovery, Antigen Discovery, as Director from 1997 to 2003, and Argos Therapeutics, Inc., as Chief Scientific Officer from 2007 to 2018.
Dr. Nicolette received his undergraduate degree and doctorate degree from The State University of New York.
Anciens postes connus de Charles A. Nicolette
| Sociétés | Poste | Fin |
|---|---|---|
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cell-based therapeutics | Directeur Général | 01/03/2025 |
| ARGOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 30/11/2018 |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics and diagnostics | Corporate Officer/Principal | 01/01/2003 |
Antigen Discovery
Antigen Discovery Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development, specifically focusing on identifying & characterizing antigens for diagnostic, vaccine, or therapeutic purposes | Directeur/Membre du Conseil | 01/01/2003 |
Formation de Charles A. Nicolette
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics and diagnostics | Health Technology |
Antigen Discovery
Antigen Discovery Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development, specifically focusing on identifying & characterizing antigens for diagnostic, vaccine, or therapeutic purposes | Commercial Services |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cell-based therapeutics | Health Technology |
















